Do not use in lactating dairy cows with a known hypersensitivity to cefalexin and/or kanamycin.
Do not use in non-lactating cattle.
Do not use in the case of known resistance of cefalexin and/or kanamycin.
Special precautions for use in animals
The product should be used for treatment of clinical mastitis only.
Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional and farm level) epidemiological information about susceptibility of the target bacteria as well as by taking into account official national antimicrobial policies. Inappropriate use of the product may increase the prevalence of bacteria resistant to cefalexin and kanamycin and may decrease the effectiveness of treatment with other cephalosporins or aminoglycosides due to the potential for cross-resistance.
Special precautions for the user
Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead to cross sensitivity to cephalosporin and vice versa. Allergic reactions to these substances may occasionally be serious.
1Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations.
2Take all recommended precautions. Handle this product with great care to avoid exposure by accidental contact with the skin. It is recommended to wear gloves when handling or administering the product . Wash exposed skin after use.
3If you develop symptoms following exposure, such as skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips and eyes or difficulty in breathing are more serious symptoms and require urgent medical attention.Studies in laboratory animals have not produced any evidence of teratogenic effect. Field studies in dairy cows have not produced any evidence of a teratogenic, foetotoxic or maternotoxic effect. The product can be used in pregnant cows.
The product is intended for use during lactation.
In general, combination with bacteriostatic antimicrobials should be avoided. In case of resistance to cefalexin, cross-resistance with other cephalosporins is likely to occur. In case of resistance to kanamycin, cross-resistance occurs between kanamycin, neomycin and paromomycin. A one way resistance with streptomycin is known.
Withdrawal periods
Meat and offal: 10 days
Milk: 5 days